Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Breakthrough Prize in Life Sciences

- PMLiVE

Is print the new vinyl?

The release of the National Medical Readership Survey prompts the inevitable discussion about the role of print vs. other channels in the marketing mix, when targeting GPs and HCPs generally...

UK flag

May says UK’s science base is a “negotiating priority” for Brexit

Stokes confidence in UK pharma as science and innovation featured among 12 key priorities

- PMLiVE

Merck forges cancer-focused big data alliance with Palantir

Plans to develop a collaborative analytics platform to accelerate research and improve outcomes

Challenging times

It’s not an easy time for pharma, but there are opportunities for those companies that are willing to be true game changers

- PMLiVE

The modern doctor is a digital nomad

How social networks have become the primary individual communication platforms for healthcare professionals

- PMLiVE

Don’t you forget about me

Are we neglecting the needs of those on the fringes of digital?

- PMLiVE

The future of biotech

What impact will the sector, and its R&D performance, have on pharma?

- PMLiVE

2017 Trends in healthcare – how advances in technology are influencing the expert-patient relationship

In the 2017 trends edition of Perspective magazine, we explore how advances in technology are influencing the future of the expert-patient relationship and the role healthcare businesses can take in...

Blue Latitude Health

- PMLiVE

J&J partner drive nets 15 new deals, and another NASH drug

Fosters new collaborations in treatment-resistant depression, infectious diseases and cancer

- PMLiVE

Bob Chandler launches new healthcare comms ‘micro-network’

Members of Watershed Bridges include wethepeople, BK Digital and MaxAscent

- PMLiVE

Digital home care platform launched in the UK

The Vida service matches carers with clients to bridge home care gaps

Bayer symbol

Bayer helps bankroll new stem cell company BlueRock

Start-up receives $225m to develop cardiovascular and neurodegenerative disease therapies

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links